2025 was a defining year for Autonomize AI.
We established early leadership in healthcare AI within our initial focus area: payers and health plans. Over the course of the year, we became one of the few names that consistently surface in serious customer and investor conversations—and the only one demonstrating AI operating in production, at scale, across multiple workflows within large national and regional healthcare enterprises.
Today, we are likely the only platform simultaneously serving three of the top five healthcare organizations in the country: a major national government plan, the largest PBM, and a large national commercial payer. This is enterprise AI in the real world—handling complexity, volume, and regulatory rigor without compromise.
Just as importantly, we made real progress toward our mission: making healthcare more seamless for patients, more efficient for enterprises, and more humane for the professionals who deliver care.
Momentum in 2025
We entered 2025 with tangible proof points—Fortune 100 health plan deployments showing AI operating at scale. That momentum continued with the launch of new AI-native applications (formerly AI Copilots) and our partnership with Altais Health Solutions.
As the year progressed, the market began to validate a core belief we have held from the beginning: healthcare does not need more point solutions. It needs an enterprise-grade AI operating model.
In June, we announced our Series A, welcoming Tier-1 investors including Valtruis, Cigna Group Ventures, and Tau Ventures. We also strengthened the leadership team across growth, solutions engineering, and strategic advisory—building the foundation required for sustained scale.
Execution remained relentless throughout the year:
- Enabled the largest PBM in the country to streamline pharmacy prior authorization and materially reduce rework
- Deployed more than 100 AI agents in production at a national health plan across Utilization Management, Care Management, Quality, and Claims
- Delivered tens of millions of dollars in savings, moving decisively beyond pilots and proofs of concept
In the second half of the year, we opened the platform more broadly with the launch of AI Studio and the Marketplace. Customers can now model, test, validate, and deploy AI agents and multi-agent workflows with regulatory-grade trust and enterprise governance built in. The impact has been immediate: shorter time-to-value, lower risk, and increased velocity.
The Business
- ARR grew nearly 3× year over year in 2025
- The team scaled to 2x across the U.S., Canada, and India
- We exited the year positioned for a breakout 2026
Why 2026 Will Be Bigger
The market is ready.
Healthcare is no longer experimenting with AI at the margins. Structural pressure—rising costs, workforce shortages, and operational complexity—is forcing real change. AI is no longer optional. It is becoming the only viable path forward.
We have built a uniquely scalable platform.
Autonomize AI was designed from the ground up for healthcare enterprises, meeting organizations wherever they are in their journey:
- Ready-to-deploy AI-native applications for workflows like Prior Authorization, Correspondence, and Payment Integrity
- Composable workflows powered by a marketplace of healthcare-specific AI agents
- Full-stack AI enablement for organizations building from first principles
Very few companies can operate across this spectrum. We can—and do.
We know how to make AI work in the real world.
Our differentiation is not tooling. It is execution. We have delivered outcomes at scale that others still talk about in theory. Over time, we have built the organizational muscle to take customers from model selection to multi-agent system design to clinical and operational change management. This is full-stack execution in production environments, not experimentation.
Looking Ahead
As we enter 2026, a clear shift is underway in healthcare operations.
The industry is moving beyond task-level automation toward agent-driven systems that span entire workflows. Routine, high-volume work is increasingly handled by AI, while agents operate alongside licensed professionals—augmenting judgment and execution, not attempting to replace them.
The result is a hybrid enterprise by design. AI agents manage predictable work at scale. Humans supervise, train, intervene, and resolve exceptions. Decision cycles compress. Throughput increases. Variability declines. This is not incremental optimization—it is a structural change in how healthcare operates.
As these systems mature, longstanding friction begins to look less inevitable. When information and context move freely across workflows, and parts of those workflows can reason and act autonomously, handoffs, silos, and manual checkpoints become design choices—not constraints.
This enables a different operating model. Healthcare organizations evolve into learning enterprises: systems that continuously adapt based on real-world outcomes, with governance and human oversight embedded from the start. Over time, operations shift from assisted execution to increasingly autonomous ones—without sacrificing trust or accountability.
The impact is material. Organizations become more resilient and economically sustainable. Clinicians spend more time working at the top of their license. Patients experience care that is faster, more coordinated, and more personal.
This is no longer theoretical. The capabilities exist, adoption is accelerating, and 2026 is likely to be the year these changes begin to compound.
We intend to be at the center of that shift.
Thank you to our teams in North America and India. Let’s make 2026 happen.
